Kairos Pharma Launches $6.2 Million IPO to Advance Cancer Therapies
Kairos Pharma Launches Initial Public Offering
Kairos Pharma, Ltd. is excited to announce that it has priced its initial public offering of common stock, aiming to generate $6.2 million in gross proceeds. This IPO consists of 1,550,000 shares priced at $4.00 each, with a potential additional 232,500 shares available through an option for underwriters. This strategic move marks an important milestone for the company in its mission to develop innovative cancer treatments.
Investing in Innovative Cancer Therapies
The funds raised from this public offering will directly support the company's clinical trials. Specifically, Kairos Pharma plans to utilize these proceeds to advance its Phase 1 trial in lung cancer and a Phase 2 trial focused on prostate cancer. These trials will center around their lead product candidate, ENV 105, which aims to counteract drug resistance and bolster the efficacy of existing cancer treatments.
Company Overview and Therapeutic Pipeline
Kairos Pharma, headquartered in Los Angeles, is at the forefront of biopharmaceutical development, particularly in the oncology sector. The company is dedicated to creating therapies that not only target cancer cells but also enhance the immune system's ability to fight off cancer. The imaginative pipeline includes ENV 105 and other promising candidates, such as KROS 101, designed to enhance T cell functions against tumors, showcasing the company's commitment to innovative solutions.
Joining the NYSE American
The common stock has received approval for listing on the NYSE American under the ticker symbol "KAPA." Trading is anticipated to commence shortly after the offering closes, opening new avenues for investment and collaboration.
The Role of Underwriters in the Offering
In this public offering, Boustead Securities, LLC serves as the lead managing underwriter, supported by EF Hutton LLC. Their expertise is invaluable in navigating the complexities of the financial markets and ensuring a successful IPO.
How Will the Funds Be Used?
The proceeds from this public offering will significantly accelerate the development of key projects. The company’s focus on reversing resistance to standard therapies highlights its extraordinary potential to change treatment paradigms in oncology.
Regulatory Approvals and Future Steps
A Form S-1 registration statement concerning the offering has been authorized by the Securities and Exchange Commission, which is a crucial step for public visibility and compliance. This procedural framework ensures transparency and reassures investors about the legitimacy of their investments.
Company Contact Information
For those interested in further engagement or inquiries about the offering or company initiatives, communication can be directed to CORE IR, specifically Louie Toma via email at investors@kairospharma.com.
Frequently Asked Questions
What is the purpose of the IPO for Kairos Pharma?
The IPO aims to raise funds to support clinical trials and develop innovative cancer therapies, including ENV 105.
When will the stock begin trading?
The trading of Kairos Pharma's common stock is expected to commence shortly after the offering conclusion under the ticker symbol "KAPA."
How much capital is Kairos Pharma raising through the IPO?
Kairos Pharma is seeking to raise approximately $6.2 million in gross proceeds from the initial public offering.
Who are the underwriters for the offering?
Boustead Securities, LLC is the lead managing underwriter, assisted by EF Hutton LLC for the IPO.
What is the main focus of Kairos Pharma's research?
Kairos Pharma focuses on developing therapies that tackle cancer drug resistance and boost the immune system's response to cancer treatments.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Coinbase Investors Alert: Class Action Lawsuit Filed – Know Your Rights
- MacroGenics Class Action Alert: Investors Entitled to Relief
- ePlus Inc. Revamps Incentive Plan to Strengthen Governance
- Intel's Strategic Move to Partner with Amazon's AWS Boosts Prospects
- Important Legal Insights for XPEL, Inc. Investors
- Home BancShares, Inc. Prepares to Announce Earnings Results
- Analysis of DexCom's Recent Challenges and Stock Decline
- Colombia Stock Market Sees Positive Trend as COLCAP Gains
- Russia's Military Expansion and its Impact on Defense Stocks
- Taylor Family Investments Sells Over $1.3 Million in AVO Stock
Recent Articles
- Collaborative Efforts Between LSU and Integer to Enhance Naval Tech
- Intel Stock Surges Following Pentagon Grant News
- Historic Hyde Park Condo Once Home to the Obamas Up for Sale
- LSU and Integer Technologies Join Forces for Naval Innovation
- Revolutionizing Excel: Anaconda Launches Python Integration
- Overview of the Growing Facial Serum Industry Landscape
- Bayer Enhances Prostate Cancer Therapy with Darolutamide Progress
- Anticipated Growth of OLED Market to $344.58 Billion by 2034
- Analyzing MARA Holdings' Options Activity and Market Trends
- Understanding the Implications of Potential Interest Rate Cuts
- Golden Silk Pheach and Public Masterpiece: A New Era Begins
- Oracle's Options Market Activity Evidences Strong Investor Interest
- Verizon Steps Up with $25,000 for Wildfire Relief in California
- Exploring ASML Holdings: Insights into Options Trading Trends
- Exciting Launch of the Next Gen Koss Porta Pro Wireless Headphones
- EA SPORTS FC™ 25 Soundtrack: A Melodic Global Experience
- Ress Life Investments A/S Reports Impressive NAV Figures Today
- Microsoft's Competitive Landscape in the Software Industry
- Varcode Introduces Smart Tag VI™: The Future of Cold Chain Safety
- Ethereum Sees Significant 5% Drop in Recent Trading Hours
- Exciting Fall Flavors and High Holiday Delicacies Await
- Insider Trading Surge: Impinj's $20M Stock Investment
- A Deep Dive into Tesla's Competitive Edge in the Auto Market
- KBRA Earns Prestigious Title as Leading Ratings Provider
- Taiwan Semiconductor: A Deeper Look Into Its Competitive Edge
- Investors at Odds: Legal Action for Oddity Tech Ltd. Misconduct
- LTK Co-Pilot: Revolutionizing Creator Commerce with New Tools
- Bitcoin Experiences Notable Price Fluctuation Amid Trends
- How a Small Investment in Oracle Created Massive Returns
- Wealth.com Secures $30 Million to Innovate Estate Planning Solutions
- Dogecoin Price Experiences Notable Decline Amid Trading Trends
- Lucy Deus: Celebrating Innovation in Supply Chain Leadership
- Advance Your Marketing with LTK's Innovative Solutions
- Solana's Price Fluctuation: Analyzing Recent Market Trends
- BNB Struggles As Prices Dip Over 3% Within A Day
- Life360 Unveils Revolutionary Tile Trackers with SOS Capability
- NIQ's Innovative AI Solutions for CPG Brands at Festival 2024
- Exploring Silver's Potential in the AI Era: What Investors Should Know
- Hoag's New $25 Million Addiction Treatment Facility Unveiled
- WitnessAI Empowers Security with Microsoft Copilot Integration
- Opportunity for Investors to Engage in Oddity Tech Class Action
- Discover Wolves: A Trailblazer in American Whiskey Innovation
- Why Advantest Corp. (ATEYY) Is Trending Upward in 2024
- Exciting New Teasers Unveiled for the 'DAN DA DAN' Anime
- Exploring the Surge in Cannabis Debt Market Activity
- The Importance of Legal Guidance During License Suspensions
- Legal Leaders Robert Hur and Leah Grossi Return to King & Spalding
- Post Malone Partners with Poppi to Transform Soda Industry
- Israel's Tech Sector: Resilience Amid Regional Challenges
- Midori & Friends Expands Leadership with New Board Members